HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path

Continue Your Learning

Posted by
HealthTree image
HealthTree
Last updated and reviewed on: March 31, 2025

Read 

  • MRD Negativity: A Key Predictor for Multiple Myeloma Outcomes

Watch 

  • How is MRD Testing Done? 
  • (2022) SoCal Myeloma Community Chapter: Minimal Residual Disease (MRD) clonoSEQ Testing- What Is It? How Can It Help You?
  • (2022) Testing Minimal Residual Disease in Non-Secretory Myeloma Patients with clonoSEQ
  • Blood Monitored MRD Testing for Non-Secretory Myeloma
  • Detecting Minimal Residual Disease | Dory Abelman, PhD(c) | IMS 2024
  • ImmunoPET- an Advanced Companion to MRD Testing Webinar with Dr. Ola Landgren 

View 

User uploaded media

 

User uploaded media

Related Content

  • Event Measurable Residual Disease in ALL
  • Video What is the significance of minimal residual disease and guiding ALL treatment decision?
  • News How MRD Status Could Help Predict Outcomes for People with High-Risk ALL